Article
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study.
The pharmacogenomics journal - 1 Jun 2016
Boldrin E, Rumiato E, Fassan M, Rugge M, Cagol M, Marino D, Chiarion-Sileni V, Ruol A, Gusella M, Pasini F, Amadori A, Saggioro D
Abstract excerpt
The occurrence of a second primary esophageal carcinoma (EC) in long-term cancer survivors may represent a late effect of previous radio-chemotherapeutic treatment. To identify the genetic factors that could increase this risk, we analyzed nine variants within ERCC1, XPD, XRCC1 and XRCC3 DNA repair pathway genes, and GSTP1, TP53 and MDM2 genes in 61 patients who received radio-chemotherapy for a prior lymphoma or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
